NCT00980200View on ClinicalTrials.gov

Efficacy and Safety Study in Subjects With Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Asthma
Interventions
DRUG

Dose 4 QD

QD once daily

DRUG

Dose 3 QD

QD once daily

DRUG

placebo

placebo

DRUG

Dose 2 QD

QD once daily

DRUG

Dose 1 BD

BD twice daily

Trial Locations (9)

20814

GSK Investigational Site, Bethesda

27607

GSK Investigational Site, Raleigh

29118

GSK Investigational Site, Orangeburg

65401

GSK Investigational Site, Rolla

73103

GSK Investigational Site, Oklahoma City

78006

GSK Investigational Site, Boerne

90630

GSK Investigational Site, Cypress

92647

GSK Investigational Site, Huntington Beach

97504

GSK Investigational Site, Medford

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY